Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

IMPACT Therapeutics synthesizes new NUAK inhibitors

June 28, 2022

Chengdu Easton Biopharmaceuticals discloses BET inhibitors

June 28, 2022

Molecular signature predicts cancer risk in patients with NAFLD

June 27, 2022

First preclinical data on NR2F6 antagonist TES-4207

June 27, 2022

FDA clears Fusion's IND applications for FPI-2059 and imaging analogue FPI-2058

June 27, 2022

Merck & Co. identifies new GLCT-1 inhibitors

June 27, 2022

Sumitomo Pharma divulges Chk1 inhibitors

June 27, 2022

Servier patents new MAT2A inhibitors

June 27, 2022

Novel murine model may shed light for future strategies for aggressive glioblastoma

June 27, 2022

Inhibitor harms leukemic stem cells while boosting normal ones

June 23, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...